Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Febrile Neutropenia Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Pegfilgrastim
1.2.3 Vancomycin Hydrochloride
1.2.4 Filgrastim Biosimilars
1.2.5 Pegfilgrastim Biosimilars
1.2.6 Others
1.3 Market by Application
1.3.1 Global Febrile Neutropenia Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Febrile Neutropenia Market Perspective (2018-2034)
2.2 Febrile Neutropenia Growth Trends by Region
2.2.1 Global Febrile Neutropenia Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Febrile Neutropenia Historic Market Size by Region (2018-2023)
2.2.3 Febrile Neutropenia Forecasted Market Size by Region (2024-2034)
2.3 Febrile Neutropenia Market Dynamics
2.3.1 Febrile Neutropenia Industry Trends
2.3.2 Febrile Neutropenia Market Drivers
2.3.3 Febrile Neutropenia Market Challenges
2.3.4 Febrile Neutropenia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Febrile Neutropenia Players by Revenue
3.1.1 Global Top Febrile Neutropenia Players by Revenue (2018-2023)
3.1.2 Global Febrile Neutropenia Revenue Market Share by Players (2018-2023)
3.2 Global Febrile Neutropenia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Febrile Neutropenia Revenue
3.4 Global Febrile Neutropenia Market Concentration Ratio
3.4.1 Global Febrile Neutropenia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Febrile Neutropenia Revenue in 2024
3.5 Febrile Neutropenia Key Players Head office and Area Served
3.6 Key Players Febrile Neutropenia Product Solution and Service
3.7 Date of Enter into Febrile Neutropenia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Febrile Neutropenia Breakdown Data by Type
4.1 Global Febrile Neutropenia Historic Market Size by Type (2018-2023)
4.2 Global Febrile Neutropenia Forecasted Market Size by Type (2024-2034)
5 Febrile Neutropenia Breakdown Data by Application
5.1 Global Febrile Neutropenia Historic Market Size by Application (2018-2023)
5.2 Global Febrile Neutropenia Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Febrile Neutropenia Market Size (2018-2034)
6.2 North America Febrile Neutropenia Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Febrile Neutropenia Market Size by Country (2018-2023)
6.4 North America Febrile Neutropenia Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Febrile Neutropenia Market Size (2018-2034)
7.2 Europe Febrile Neutropenia Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Febrile Neutropenia Market Size by Country (2018-2023)
7.4 Europe Febrile Neutropenia Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Febrile Neutropenia Market Size (2018-2034)
8.2 Asia-Pacific Febrile Neutropenia Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Febrile Neutropenia Market Size by Region (2018-2023)
8.4 Asia-Pacific Febrile Neutropenia Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Febrile Neutropenia Market Size (2018-2034)
9.2 Latin America Febrile Neutropenia Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Febrile Neutropenia Market Size by Country (2018-2023)
9.4 Latin America Febrile Neutropenia Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Febrile Neutropenia Market Size (2018-2034)
10.2 Middle East & Africa Febrile Neutropenia Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Febrile Neutropenia Market Size by Country (2018-2023)
10.4 Middle East & Africa Febrile Neutropenia Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Xenetic Biosciences, Inc. (XBIO)
11.1.1 Xenetic Biosciences, Inc. (XBIO) Company Detail
11.1.2 Xenetic Biosciences, Inc. (XBIO) Business Overview
11.1.3 Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Introduction
11.1.4 Xenetic Biosciences, Inc. (XBIO) Revenue in Febrile Neutropenia Business (2018-2023)
11.1.5 Xenetic Biosciences, Inc. (XBIO) Recent Development
11.2 Richter Gedeon Nyrt.
11.2.1 Richter Gedeon Nyrt. Company Detail
11.2.2 Richter Gedeon Nyrt. Business Overview
11.2.3 Richter Gedeon Nyrt. Febrile Neutropenia Introduction
11.2.4 Richter Gedeon Nyrt. Revenue in Febrile Neutropenia Business (2018-2023)
11.2.5 Richter Gedeon Nyrt. Recent Development
11.3 Amgen Inc.
11.3.1 Amgen Inc. Company Detail
11.3.2 Amgen Inc. Business Overview
11.3.3 Amgen Inc. Febrile Neutropenia Introduction
11.3.4 Amgen Inc. Revenue in Febrile Neutropenia Business (2018-2023)
11.3.5 Amgen Inc. Recent Development
11.4 Hospira, Inc.
11.4.1 Hospira, Inc. Company Detail
11.4.2 Hospira, Inc. Business Overview
11.4.3 Hospira, Inc. Febrile Neutropenia Introduction
11.4.4 Hospira, Inc. Revenue in Febrile Neutropenia Business (2018-2023)
11.4.5 Hospira, Inc. Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Detail
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Febrile Neutropenia Introduction
11.5.4 Eli Lilly and Company Revenue in Febrile Neutropenia Business (2018-2023)
11.5.5 Eli Lilly and Company Recent Development
11.6 USV Private Limited
11.6.1 USV Private Limited Company Detail
11.6.2 USV Private Limited Business Overview
11.6.3 USV Private Limited Febrile Neutropenia Introduction
11.6.4 USV Private Limited Revenue in Febrile Neutropenia Business (2018-2023)
11.6.5 USV Private Limited Recent Development
11.7 Aequus BioPharma, Inc.
11.7.1 Aequus BioPharma, Inc. Company Detail
11.7.2 Aequus BioPharma, Inc. Business Overview
11.7.3 Aequus BioPharma, Inc. Febrile Neutropenia Introduction
11.7.4 Aequus BioPharma, Inc. Revenue in Febrile Neutropenia Business (2018-2023)
11.7.5 Aequus BioPharma, Inc. Recent Development
11.8 Taiho Pharmaceutical Co., Ltd.
11.8.1 Taiho Pharmaceutical Co., Ltd. Company Detail
11.8.2 Taiho Pharmaceutical Co., Ltd. Business Overview
11.8.3 Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Introduction
11.8.4 Taiho Pharmaceutical Co., Ltd. Revenue in Febrile Neutropenia Business (2018-2023)
11.8.5 Taiho Pharmaceutical Co., Ltd. Recent Development
11.9 BeyondSpring Inc.
11.9.1 BeyondSpring Inc. Company Detail
11.9.2 BeyondSpring Inc. Business Overview
11.9.3 BeyondSpring Inc. Febrile Neutropenia Introduction
11.9.4 BeyondSpring Inc. Revenue in Febrile Neutropenia Business (2018-2023)
11.9.5 BeyondSpring Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Febrile Neutropenia Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Pegfilgrastim
Table 3. Key Players of Vancomycin Hydrochloride
Table 4. Key Players of Filgrastim Biosimilars
Table 5. Key Players of Pegfilgrastim Biosimilars
Table 6. Key Players of Others
Table 7. Global Febrile Neutropenia Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global Febrile Neutropenia Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 9. Global Febrile Neutropenia Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Febrile Neutropenia Market Share by Region (2018-2023)
Table 11. Global Febrile Neutropenia Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 12. Global Febrile Neutropenia Market Share by Region (2024-2034)
Table 13. Febrile Neutropenia Market Trends
Table 14. Febrile Neutropenia Market Drivers
Table 15. Febrile Neutropenia Market Challenges
Table 16. Febrile Neutropenia Market Restraints
Table 17. Global Febrile Neutropenia Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Febrile Neutropenia Market Share by Players (2018-2023)
Table 19. Global Top Febrile Neutropenia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Febrile Neutropenia as of 2024)
Table 20. Ranking of Global Top Febrile Neutropenia Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Febrile Neutropenia Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Febrile Neutropenia Product Solution and Service
Table 24. Date of Enter into Febrile Neutropenia Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Febrile Neutropenia Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Febrile Neutropenia Revenue Market Share by Type (2018-2023)
Table 28. Global Febrile Neutropenia Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 29. Global Febrile Neutropenia Revenue Market Share by Type (2024-2034)
Table 30. Global Febrile Neutropenia Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Febrile Neutropenia Revenue Market Share by Application (2018-2023)
Table 32. Global Febrile Neutropenia Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 33. Global Febrile Neutropenia Revenue Market Share by Application (2024-2034)
Table 34. North America Febrile Neutropenia Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. North America Febrile Neutropenia Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Febrile Neutropenia Market Size by Country (2024-2034) & (US$ Million)
Table 37. Europe Febrile Neutropenia Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. Europe Febrile Neutropenia Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Febrile Neutropenia Market Size by Country (2024-2034) & (US$ Million)
Table 40. Asia-Pacific Febrile Neutropenia Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 41. Asia-Pacific Febrile Neutropenia Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Febrile Neutropenia Market Size by Region (2024-2034) & (US$ Million)
Table 43. Latin America Febrile Neutropenia Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Latin America Febrile Neutropenia Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Febrile Neutropenia Market Size by Country (2024-2034) & (US$ Million)
Table 46. Middle East & Africa Febrile Neutropenia Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 47. Middle East & Africa Febrile Neutropenia Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Febrile Neutropenia Market Size by Country (2024-2034) & (US$ Million)
Table 49. Xenetic Biosciences, Inc. (XBIO) Company Detail
Table 50. Xenetic Biosciences, Inc. (XBIO) Business Overview
Table 51. Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Product
Table 52. Xenetic Biosciences, Inc. (XBIO) Revenue in Febrile Neutropenia Business (2018-2023) & (US$ Million)
Table 53. Xenetic Biosciences, Inc. (XBIO) Recent Development
Table 54. Richter Gedeon Nyrt. Company Detail
Table 55. Richter Gedeon Nyrt. Business Overview
Table 56. Richter Gedeon Nyrt. Febrile Neutropenia Product
Table 57. Richter Gedeon Nyrt. Revenue in Febrile Neutropenia Business (2018-2023) & (US$ Million)
Table 58. Richter Gedeon Nyrt. Recent Development
Table 59. Amgen Inc. Company Detail
Table 60. Amgen Inc. Business Overview
Table 61. Amgen Inc. Febrile Neutropenia Product
Table 62. Amgen Inc. Revenue in Febrile Neutropenia Business (2018-2023) & (US$ Million)
Table 63. Amgen Inc. Recent Development
Table 64. Hospira, Inc. Company Detail
Table 65. Hospira, Inc. Business Overview
Table 66. Hospira, Inc. Febrile Neutropenia Product
Table 67. Hospira, Inc. Revenue in Febrile Neutropenia Business (2018-2023) & (US$ Million)
Table 68. Hospira, Inc. Recent Development
Table 69. Eli Lilly and Company Company Detail
Table 70. Eli Lilly and Company Business Overview
Table 71. Eli Lilly and Company Febrile Neutropenia Product
Table 72. Eli Lilly and Company Revenue in Febrile Neutropenia Business (2018-2023) & (US$ Million)
Table 73. Eli Lilly and Company Recent Development
Table 74. USV Private Limited Company Detail
Table 75. USV Private Limited Business Overview
Table 76. USV Private Limited Febrile Neutropenia Product
Table 77. USV Private Limited Revenue in Febrile Neutropenia Business (2018-2023) & (US$ Million)
Table 78. USV Private Limited Recent Development
Table 79. Aequus BioPharma, Inc. Company Detail
Table 80. Aequus BioPharma, Inc. Business Overview
Table 81. Aequus BioPharma, Inc. Febrile Neutropenia Product
Table 82. Aequus BioPharma, Inc. Revenue in Febrile Neutropenia Business (2018-2023) & (US$ Million)
Table 83. Aequus BioPharma, Inc. Recent Development
Table 84. Taiho Pharmaceutical Co., Ltd. Company Detail
Table 85. Taiho Pharmaceutical Co., Ltd. Business Overview
Table 86. Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Product
Table 87. Taiho Pharmaceutical Co., Ltd. Revenue in Febrile Neutropenia Business (2018-2023) & (US$ Million)
Table 88. Taiho Pharmaceutical Co., Ltd. Recent Development
Table 89. BeyondSpring Inc. Company Detail
Table 90. BeyondSpring Inc. Business Overview
Table 91. BeyondSpring Inc. Febrile Neutropenia Product
Table 92. BeyondSpring Inc. Revenue in Febrile Neutropenia Business (2018-2023) & (US$ Million)
Table 93. BeyondSpring Inc. Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Febrile Neutropenia Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Febrile Neutropenia Market Share by Type: 2024 VS 2034
Figure 3. Pegfilgrastim Features
Figure 4. Vancomycin Hydrochloride Features
Figure 5. Filgrastim Biosimilars Features
Figure 6. Pegfilgrastim Biosimilars Features
Figure 7. Others Features
Figure 8. Global Febrile Neutropenia Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Febrile Neutropenia Market Share by Application: 2024 VS 2034
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Febrile Neutropenia Report Years Considered
Figure 14. Global Febrile Neutropenia Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 15. Global Febrile Neutropenia Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Febrile Neutropenia Market Share by Region: 2024 VS 2034
Figure 17. Global Febrile Neutropenia Market Share by Players in 2024
Figure 18. Global Top Febrile Neutropenia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Febrile Neutropenia as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Febrile Neutropenia Revenue in 2024
Figure 20. North America Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. North America Febrile Neutropenia Market Share by Country (2018-2034)
Figure 22. United States Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Febrile Neutropenia Market Share by Country (2018-2034)
Figure 26. Germany Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. France Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. U.K. Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Italy Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Russia Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Nordic Countries Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Asia-Pacific Febrile Neutropenia Market Share by Region (2018-2034)
Figure 34. China Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Japan Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. South Korea Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Southeast Asia Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. India Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Australia Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Latin America Febrile Neutropenia Market Share by Country (2018-2034)
Figure 42. Mexico Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Brazil Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East & Africa Febrile Neutropenia Market Share by Country (2018-2034)
Figure 46. Turkey Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Saudi Arabia Febrile Neutropenia Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Xenetic Biosciences, Inc. (XBIO) Revenue Growth Rate in Febrile Neutropenia Business (2018-2023)
Figure 49. Richter Gedeon Nyrt. Revenue Growth Rate in Febrile Neutropenia Business (2018-2023)
Figure 50. Amgen Inc. Revenue Growth Rate in Febrile Neutropenia Business (2018-2023)
Figure 51. Hospira, Inc. Revenue Growth Rate in Febrile Neutropenia Business (2018-2023)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Febrile Neutropenia Business (2018-2023)
Figure 53. USV Private Limited Revenue Growth Rate in Febrile Neutropenia Business (2018-2023)
Figure 54. Aequus BioPharma, Inc. Revenue Growth Rate in Febrile Neutropenia Business (2018-2023)
Figure 55. Taiho Pharmaceutical Co., Ltd. Revenue Growth Rate in Febrile Neutropenia Business (2018-2023)
Figure 56. BeyondSpring Inc. Revenue Growth Rate in Febrile Neutropenia Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed